Publication date: Aug 08, 2019
Individuals taking extended-release injection naltrexone for opioid use disorder .. . In addition, a greater percentage of patients receiving naltrexone vs . ..
| Concepts | Keywords |
|---|---|
| Extended Release | Low-dose naltrexone |
| Naltrexone | Opioid use disorder |
| Opioid | Naltrexone |
| Ketones | |
| Phenols | |
| RTT | |
| Morphinans | |
| Opioid antagonists | |
| Organic compounds | |
| Chemical compounds | |
| Opioids |
Semantics
| Type | Source | Name |
|---|---|---|
| pathway | BSID | Release |
| drug | DRUGBANK | Naltrexone |
Similar
- Youth Opioid Recovery Support: Improving Care Systems
- COMPA Members Help Researchers Study Benefits of Telemedicine in Treating Opioid Use Disorder and Hepatitis C
- Medicare going in ‘right direction’ on opioid epidemic, federal report finds